Growth Equity
Ascend Partners
Ascend Partners takes minority stakes in growing companies, usually without full control, from New York, United States. It states a focus on healthcare & life sciences.
SEC filings
What Ascend Partners has raised
From this firm's own Form D filings. A fund files one within fifteen days of its first sale, under penalty of perjury, which makes these the hardest numbers on the page.
| Vehicles filed | 8 |
| Total capital raised | $11bn |
| Largest single vehicle | $2.3bn |
| Filing history | 2014 to 2018 |
| Smallest accepted commitment | $100k |
| Filed from | CAYMAN ISLANDS |
Form D covers US-domiciled vehicles raised from accredited investors. It will not capture a fund raised outside the United States, separately managed accounts, or capital deployed off balance sheet, so treat these as a floor rather than a total.
Regulatory record
How Ascend Partners is registered
From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.
| Adviser status | SEC registered |
| Regulatory assets under management | $2.2bn |
| Employees | 19 |
| Private funds advised | 16 · $2.2bn gross |
| SEC adviser number | CRD 310515 |
Portfolio
Disclosed holdings
Companies Ascend Partners lists on its own website. 9 carry a stated investment year.
| Company | Invested | Years held | Recorded transaction |
|---|---|---|---|
| Essen Health Care | 2020 | 6 | — |
| Rendr | 2020 | 6 | — |
| Consensus Health | 2021 | 5 | — |
| Ilumed | 2021 | 5 | — |
| Allied Physicians Group | 2022 | 4 | — |
| Elation Health | 2022 | 4 | — |
| MSPB | 2022 | 4 | — |
| Seoul Medical Group | 2023 | 3 | — |
| Unison | 2024 | 2 | — |
Compiled from Ascend Partners’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.
Valuation context
Transaction values in Healthcare & Life Sciences
What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.
The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Is this Ascend Partners?
Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.
Claim or correct this profileTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.
Comparable investors
Similar mandates
Other growth equity investors active in healthcare & life sciences.